腫瘍壊死因子阻害剤およびインターロイキン-17阻害剤に抵抗性の汎発性膿疱性乾癬患者におけるスペソリマブ投与による手掌・足裏膿疱の改善　症例報告(Spesolimab improved pustules on the palms and soles that were refractory to tumor necrosis factor inhibitors and interleukin-17 inhibitors in a patient with generalized pustular psoriasis: A case report)

Suzuki Shoya; Kamata Masahiro; Ito Makoto; Watanabe Ayu; Uchida Hideaki; Chijiwa Chika; Azuma Saori; Hayashi Kotaro; Sugiura Kazumitsu; Tada Yayoi

腫瘍壊死因子阻害剤およびインターロイキン-17阻害剤に抵抗性の汎発性膿疱性乾癬患者におけるスペソリマブ投与による手掌・足裏膿疱の改善　症例報告(Spesolimab improved pustules on the palms and soles that were refractory to tumor necrosis factor inhibitors and interleukin-17 inhibitors in a patient with generalized pustular psoriasis: A case report)

Suzuki Shoya, Kamata Masahiro, Ito Makoto, Watanabe Ayu, Uchida Hideaki, Chijiwa Chika, Azuma Saori, Hayashi Kotaro, Sugiura Kazumitsu, Tada Yayoi

Research output: Contribution to journal › Letter › peer-review

Original language	American English
Pages (from-to)	e416-e418
Journal	Journal of Dermatology
Volume	51
Issue number	12
State	Published - Dec 2024
Externally published	Yes

Keywords

*モノクローナル抗体(治療的利用,薬理学)
皮膚疾患-手部(診断,薬物療法)
皮膚疾患-足部(診断,薬物療法)
薬物抵抗性
Interleukin-17(拮抗物質・阻害物質)
Infliximab(治療的利用)
Adalimumab(治療的利用)
Secukinumab(治療的利用)
臨床的増悪
Tumor Necrosis Factor Inhibitors(治療的利用)
*乾癬-膿疱性(診断,薬物療法)
*Spesolimab(治療的利用,薬理学)
ヒト
中年(45～64)
女

Cite this

Shoya, S., Masahiro, K., Makoto, I., Ayu, W., Hideaki, U., Chika, C., Saori, A., Kotaro, H., Kazumitsu, S., & Yayoi, T. (2024). 腫瘍壊死因子阻害剤およびインターロイキン-17阻害剤に抵抗性の汎発性膿疱性乾癬患者におけるスペソリマブ投与による手掌・足裏膿疱の改善　症例報告(Spesolimab improved pustules on the palms and soles that were refractory to tumor necrosis factor inhibitors and interleukin-17 inhibitors in a patient with generalized pustular psoriasis: A case report). Journal of Dermatology, 51(12), e416-e418.

Shoya, Suzuki ; Masahiro, Kamata ; Makoto, Ito et al. / 腫瘍壊死因子阻害剤およびインターロイキン-17阻害剤に抵抗性の汎発性膿疱性乾癬患者におけるスペソリマブ投与による手掌・足裏膿疱の改善　症例報告(Spesolimab improved pustules on the palms and soles that were refractory to tumor necrosis factor inhibitors and interleukin-17 inhibitors in a patient with generalized pustular psoriasis: A case report). In: Journal of Dermatology. 2024 ; Vol. 51, No. 12. pp. e416-e418.

@article{98f1069368db40ad802b0eabcea9fda3,

title = "腫瘍壊死因子阻害剤およびインターロイキン-17阻害剤に抵抗性の汎発性膿疱性乾癬患者におけるスペソリマブ投与による手掌・足裏膿疱の改善　症例報告(Spesolimab improved pustules on the palms and soles that were refractory to tumor necrosis factor inhibitors and interleukin-17 inhibitors in a patient with generalized pustular psoriasis: A case report)",

keywords = "*モノクローナル抗体(治療的利用,薬理学), 皮膚疾患-手部(診断,薬物療法), 皮膚疾患-足部(診断,薬物療法), 薬物抵抗性, Interleukin-17(拮抗物質・阻害物質), Infliximab(治療的利用), Adalimumab(治療的利用), Secukinumab(治療的利用), 臨床的増悪, Tumor Necrosis Factor Inhibitors(治療的利用), *乾癬-膿疱性(診断,薬物療法), *Spesolimab(治療的利用,薬理学), ヒト, 中年(45～64), 女",

author = "Suzuki Shoya and Kamata Masahiro and Ito Makoto and Watanabe Ayu and Uchida Hideaki and Chijiwa Chika and Azuma Saori and Hayashi Kotaro and Sugiura Kazumitsu and Tada Yayoi",

year = "2024",

month = dec,

language = "American English",

volume = "51",

pages = "e416--e418",

journal = "Journal of Dermatology",

issn = "0385-2407",

publisher = "John Wiley and Sons Inc",

number = "12",

}

Shoya, S, Masahiro, K, Makoto, I, Ayu, W, Hideaki, U, Chika, C, Saori, A, Kotaro, H, Kazumitsu, S & Yayoi, T 2024, '腫瘍壊死因子阻害剤およびインターロイキン-17阻害剤に抵抗性の汎発性膿疱性乾癬患者におけるスペソリマブ投与による手掌・足裏膿疱の改善　症例報告(Spesolimab improved pustules on the palms and soles that were refractory to tumor necrosis factor inhibitors and interleukin-17 inhibitors in a patient with generalized pustular psoriasis: A case report)', Journal of Dermatology, vol. 51, no. 12, pp. e416-e418.

腫瘍壊死因子阻害剤およびインターロイキン-17阻害剤に抵抗性の汎発性膿疱性乾癬患者におけるスペソリマブ投与による手掌・足裏膿疱の改善　症例報告(Spesolimab improved pustules on the palms and soles that were refractory to tumor necrosis factor inhibitors and interleukin-17 inhibitors in a patient with generalized pustular psoriasis: A case report). / Shoya, Suzuki; Masahiro, Kamata; Makoto, Ito et al.
In: Journal of Dermatology, Vol. 51, No. 12, 12.2024, p. e416-e418.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - 腫瘍壊死因子阻害剤およびインターロイキン-17阻害剤に抵抗性の汎発性膿疱性乾癬患者におけるスペソリマブ投与による手掌・足裏膿疱の改善　症例報告(Spesolimab improved pustules on the palms and soles that were refractory to tumor necrosis factor inhibitors and interleukin-17 inhibitors in a patient with generalized pustular psoriasis: A case report)

AU - Shoya, Suzuki

AU - Masahiro, Kamata

AU - Makoto, Ito

AU - Ayu, Watanabe

AU - Hideaki, Uchida

AU - Chika, Chijiwa

AU - Saori, Azuma

AU - Kotaro, Hayashi

AU - Kazumitsu, Sugiura

AU - Yayoi, Tada

PY - 2024/12

Y1 - 2024/12

KW - モノクローナル抗体(治療的利用,薬理学)

KW - 皮膚疾患-手部(診断,薬物療法)

KW - 皮膚疾患-足部(診断,薬物療法)

KW - 薬物抵抗性

KW - Interleukin-17(拮抗物質・阻害物質)

KW - Infliximab(治療的利用)

KW - Adalimumab(治療的利用)

KW - Secukinumab(治療的利用)

KW - 臨床的増悪

KW - Tumor Necrosis Factor Inhibitors(治療的利用)

KW - 乾癬-膿疱性(診断,薬物療法)

KW - Spesolimab(治療的利用,薬理学)

KW - ヒト

KW - 中年(45～64)

KW - 女

M3 - Letter

SN - 0385-2407

VL - 51

SP - e416-e418

JO - Journal of Dermatology

JF - Journal of Dermatology

IS - 12

ER -

Shoya S, Masahiro K, Makoto I, Ayu W, Hideaki U, Chika C et al. 腫瘍壊死因子阻害剤およびインターロイキン-17阻害剤に抵抗性の汎発性膿疱性乾癬患者におけるスペソリマブ投与による手掌・足裏膿疱の改善　症例報告(Spesolimab improved pustules on the palms and soles that were refractory to tumor necrosis factor inhibitors and interleukin-17 inhibitors in a patient with generalized pustular psoriasis: A case report). Journal of Dermatology. 2024 Dec;51(12):e416-e418.